BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 17869078)

  • 1. The two faces of the 15-lipoxygenase in atherosclerosis.
    Wittwer J; Hersberger M
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):67-77. PubMed ID: 17869078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and immune regulation by 12/15-lipoxygenases.
    Kühn H; O'Donnell VB
    Prog Lipid Res; 2006 Jul; 45(4):334-56. PubMed ID: 16678271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipoxygenase-isoforms in atherogenesis.
    Kühn H; Römisch I; Belkner J
    Mol Nutr Food Res; 2005 Nov; 49(11):1014-29. PubMed ID: 16270276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts.
    Vincent C; Fiancette R; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
    Leuk Res; 2008 Nov; 32(11):1756-62. PubMed ID: 18561999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.
    Hersberger M
    Clin Chem Lab Med; 2010 Aug; 48(8):1063-73. PubMed ID: 20441482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid inflammatory mediators in diabetic vascular disease.
    Natarajan R; Nadler JL
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1542-8. PubMed ID: 15166011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?
    Harvey EJ; Ramji DP
    Cardiovasc Res; 2005 Jul; 67(1):11-20. PubMed ID: 15907820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxygenase-mediated pro-radical effect of melatonin via stimulation of arachidonic acid metabolism.
    Radogna F; Sestili P; Martinelli C; Paolillo M; Paternoster L; Albertini MC; Accorsi A; Gualandi G; Ghibelli L
    Toxicol Appl Pharmacol; 2009 Jul; 238(2):170-7. PubMed ID: 19460395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.
    Rudijanto A
    Acta Med Indones; 2007; 39(1):36-43. PubMed ID: 17939209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and subcellular localization of two 15S-lipoxygenases in human cornea.
    Chang MS; Schneider C; Roberts RL; Shappell SB; Haselton FR; Boeglin WE; Brash AR
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):849-56. PubMed ID: 15728540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxygenase metabolism: roles in tumor progression and survival.
    Pidgeon GP; Lysaght J; Krishnamoorthy S; Reynolds JV; O'Byrne K; Nie D; Honn KV
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):503-24. PubMed ID: 17943411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated linoleic acid, cis-9,trans-11, is a substrate for pulmonary 15-lipoxygenase-1 in rat.
    Cho H; Gallaher DD; Csallany AS
    J Agric Food Chem; 2005 Sep; 53(18):7262-6. PubMed ID: 16131140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat.
    Ma J; Liang S; Wang Z; Zhang L; Jiang J; Zheng J; Yu L; Zheng X; Wang R; Zhu D
    J Cell Physiol; 2010 Jan; 222(1):82-94. PubMed ID: 19746421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone.
    Kruger MC; Coetzee M; Haag M; Weiler H
    Prog Lipid Res; 2010 Oct; 49(4):438-49. PubMed ID: 20600307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-induced growth of human fibroblasts is associated with an increased expression of 5-lipoxygenase.
    Berg C; Hammarström S; Herbertsson H; Lindström E; Svensson AC; Söderström M; Tengvall P; Bengtsson T
    Thromb Haemost; 2006 Nov; 96(5):652-9. PubMed ID: 17080223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of leukotrienes and lipoxygenases in glomerular injury.
    Nassar GM; Badr KF
    Miner Electrolyte Metab; 1995; 21(4-5):262-70. PubMed ID: 7565475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
    Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
    Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.